Show simple item record

Tritium labeling of potential lipophilic myelin probes

dc.contributor.authorEhrenkaufer, Richard E.en_US
dc.contributor.authorAgranoff, Bernard W.en_US
dc.contributor.authorBieszki, J.en_US
dc.contributor.authorFrey, Kirk A.en_US
dc.contributor.authorHays, S.en_US
dc.contributor.authorJewett, Douglas M.en_US
dc.date.accessioned2012-03-16T16:01:38Z
dc.date.available2012-03-16T16:01:38Z
dc.date.issued1984-01en_US
dc.identifier.citationEhrenkaufer, R. L. E.; Agranoff, B. W.; Bieszki, J.; Frey, K.; Hays, S.; Jewett, D. (1984). "Tritium labeling of potential lipophilic myelin probes." Journal of Labelled Compounds and Radiopharmaceuticals 21(1): 87-95. <http://hdl.handle.net/2027.42/90398>en_US
dc.identifier.issn0362-4803en_US
dc.identifier.issn1099-1344en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90398
dc.description.abstractTwo potential lipophilic myelin imaging agents (1,1,2,2‐tetrafluoro‐1,2‐diphenylethane and 1‐fluoroadamantane) were tritium labeled. The most effective method employed the microwave discharge activation of tritium gas technique and resulted in specific activities of 177 mCi/mmol for 1,1,2,2‐tetrafluoro‐1,2‐diphenylethane and 593 mCi/mmol for 1‐fluoroadamantane. Using this tritiation method significant amounts of tritium‐for‐fluorine substitution was also observed in the labeling of 1‐fluoroadamatane, resulting in nearly equivalent amounts of tritiated adamantane and fluoroadamantane.en_US
dc.publisherJohn Wiley & Sons, Ltd.en_US
dc.subject.otherMicrowave Discharge Labelingen_US
dc.subject.otherTritium Labelingen_US
dc.subject.otherPositron Emission Tomographyen_US
dc.subject.otherMyelinen_US
dc.subject.otherExchange Labelingen_US
dc.titleTritium labeling of potential lipophilic myelin probesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelRadiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan Hospitals, Division of Nuclear Medicine, Ann Arbor, Michigan 48109en_US
dc.contributor.affiliationotherDepartment of Biological Chemistry, Ann Arbor, Michigan 48109en_US
dc.contributor.affiliationotherNeuroscience Laboratory, Ann Arbor, Michigan 48109en_US
dc.contributor.affiliationotherDepartment of Anesthesiology, Ann Arbor, Michigan 48109en_US
dc.contributor.affiliationotherWarner Lambert/Parke‐Davis Pharmaceutical Division, Ann Arbor, Michigan 48105en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90398/1/2580210110_ftp.pdf
dc.identifier.doi10.1002/jlcr.2580210110en_US
dc.identifier.sourceJournal of Labelled Compounds and Radiopharmaceuticalsen_US
dc.identifier.citedreferenceYoung I. R., Hall A. S., Palus C. A., et. al. ‐ Lancet 14: 1063 ( 1981 )en_US
dc.identifier.citedreferenceDoyle F. H., Pennock J. M., Orr J. S. et. al. ‐ Lancet 11: 53 ( 1981 )en_US
dc.identifier.citedreferenceRE unpublished results. The MDA labeling of toslyl leucyl chloromethylketone (TLCK) resulted in a major product which was tentatively identified as 3 H‐TLMK (tosyl leucyl methyl ketone).en_US
dc.identifier.citedreferenceGordan B. E., Peng C. T., Erwin W. R. and Lemmon R. M. ‐ Int. J. Appl. Radiat. Isot. 33: 715 ( 1982 )en_US
dc.identifier.citedreferenceEhrenkaufer R. L. E., Hembree W. C., and Lieberman S., Wolf A. P. ‐ J. Amer. Chem. Soc. 99: 5005 ( 1977 )en_US
dc.identifier.citedreferenceLeo A., Hansch C., Elkins D. ‐ Chem. Rev. 71: 525 ( 1971 )en_US
dc.identifier.citedreferenceEhrenkaufer R. L. E., Wolf A. P., Hembree W. C. ‐ J. Labelled Comp. Radiopharm. 14: 271 ( 1978 )en_US
dc.identifier.citedreferenceHembree W. C., Ehrenkaufer R. L. E., Lieberman A. and Wolf A. P. ‐ J. Biol. Chem. 248: 5532 ( 1973 )en_US
dc.identifier.citedreferenceCarbon‐Fluorine Compounds. Chemistry Biochemistry And Biological Activities. A Ciba Foundation Symposium ‐ Associated Scientific Pub. Amsterdam, 1972.en_US
dc.identifier.citedreferenceCasella V., Ido T., Wolf A. P. ‐ J. Nucl. Med. 21: 750 ( 1980 )en_US
dc.identifier.citedreferenceRozen S., Brand M. ‐ J. Org. Chem. 46: 733 ( 1981 )en_US
dc.identifier.citedreferenceAlker D., Barton D. H. R., Hesse, R. H., et al ‐ Nouv. J. Chim. 4: 239 ( 1980 )en_US
dc.identifier.citedreferenceGuzikowski A. P. ‐Doctoral Thesis“ The Addition of Molecular Fluorine to Tolanes and Stilbenes ”(May 1980 ),University of Massachusetts, and R. R. MacGregor, J. Fowler,Brookhaven National Laboratory (personal communication)en_US
dc.identifier.citedreferencePeng C. T., Gordan B. E., Erwin W. R. and Lemmon R. M. ‐ Int. J. Appl. Radiat. Isot. 33: 419 ( 1982 )en_US
dc.identifier.citedreferenceDischino D. D., Wittmer S. L., Raichle M. E. and Welch M. J. ‐ J. Labeled Comp. Radiopharm. 18: 238 ( 1981 )abst.en_US
dc.identifier.citedreferenceDischino D. D., Kilbourn M. R., Raichle M. E. and Welch M. J. ‐ J. Nucl. Med. 23: P‐23 ( 1982 )abst.en_US
dc.identifier.citedreferenceFrey K. A., Wieland D. M., Brown L. E., Rogers W. L. and Agranoff B. W. ‐ Annals of Neurology 10: 214 ( 1981 )en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.